Discontinued — last reported Q3 '25
STERIS Accrued Litigation remained flat by 0.0% to $43.20M in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates higher legal risk or the recognition of new settlement obligations, which can negatively impact earnings.
Accrued litigation represents the estimated liability for legal claims and settlements that are probable and estimable....
Highly specific to the company's legal environment; peers in the pharmaceutical industry often carry similar provisions.
accrued_litigation| Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|
| Value | $48.20M | $43.20M | $43.20M | $43.20M |
| QoQ Change | — | -10.4% | +0.0% | +0.0% |